Approval · Notice of Compliance 18800 · 2016
SYNFLORIX: Notice of Compliance 18800
Issued December 21, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18800
- Date
- December 21, 2016
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNFLORIX | Not yet assigned | — |
Medicinal ingredients
- PNEUMOCOCCAL POLYSAC SEROT 1 CONJ TO PROTEIN D CARRIER PROT 1 MCG per 0.5ML
- PNEUMOCOCCAL POLYSAC SEROT 4 CONJ TO PROTEIN D CARRIER PROT 3 MCG per 0.5ML
- PNEUMOCOCCAL POLYSAC SEROT 5 CONJ TO PROTEIN D CARRIER PROT 1 MCG per 0.5ML
- PNEUMOCOCCAL POLYSAC SEROT 6B CONJ TO PROTEIN D CARRIER PROT 1 MCG per 0.5ML
- PNEUMOCOCCAL POLYSAC SEROT 7F CONJ TO PROTEIN D CARRIER PROT 1 MCG per 0.5ML
- PNEUMOCOCCAL POLYSAC SEROT 9V CONJ TO PROTEIN D CARRIER PROT 1 MCG per 0.5ML
- PNEUMOCOCCAL POLYSAC SEROT 14 CONJ TO PROTEIN D CARRIER PROT 3 MCG per 0.5ML
- PNEUMOCOCCAL POLYSAC SEROT 18C CONJ TO TETANUS TOXOID CARRIER PROT 3 MCG per 0.5ML
- PNEUMOCOCCAL POLYSAC SEROT 19F CONJ TO DIPHT TOXOID CARRIER PROT 3 MCG per 0.5ML
- PNEUMOCOCCAL POLYSAC SEROT 23F CONJ TO PROTEIN D CARRIER PROT 1 MCG per 0.5ML